| Secondary |
| Product Used For Unknown Indication |
41.0% |
| Drug Use For Unknown Indication |
14.4% |
| Pain |
4.2% |
| Ill-defined Disorder |
4.1% |
| Rheumatoid Arthritis |
3.9% |
| Schizophrenia |
3.9% |
| Depression |
3.4% |
| Suicide Attempt |
3.1% |
| Cancer Pain |
2.7% |
| Hypertension |
2.7% |
| Mental Disorder |
2.3% |
| Migraine |
2.2% |
| Drug Exposure During Pregnancy |
1.8% |
| Foetal Exposure During Pregnancy |
1.6% |
| Medical Diet |
1.6% |
| Back Pain |
1.4% |
| Crohn's Disease |
1.4% |
| Herpes Zoster |
1.4% |
| Diarrhoea |
1.4% |
| Insomnia |
1.3% |
|
| Toxicity To Various Agents |
17.0% |
| Suicide Attempt |
9.3% |
| Death |
5.2% |
| Loss Of Consciousness |
5.2% |
| Nausea |
5.2% |
| Vomiting |
5.2% |
| Wrong Technique In Drug Usage Process |
5.2% |
| Product Quality Issue |
4.6% |
| Somnolence |
4.6% |
| Drug Ineffective |
4.1% |
| Weight Decreased |
4.1% |
| Weight Increased |
4.1% |
| Drug Toxicity |
3.6% |
| Pneumonia |
3.6% |
| Psychotic Disorder |
3.6% |
| Completed Suicide |
3.1% |
| Erythema Multiforme |
3.1% |
| Hypersensitivity |
3.1% |
| Intestinal Obstruction |
3.1% |
| Pain |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.9% |
| Drug Use For Unknown Indication |
9.0% |
| Hypertension |
8.8% |
| Pain |
8.0% |
| Rheumatoid Arthritis |
7.2% |
| Crohn's Disease |
3.6% |
| Asthma |
3.5% |
| Depression |
3.4% |
| Blood Pressure |
3.4% |
| Diabetes Mellitus |
3.3% |
| Blood Cholesterol Increased |
3.1% |
| Psoriasis |
2.9% |
| Prophylaxis |
2.8% |
| Back Pain |
2.8% |
| Anxiety |
2.0% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Blood Cholesterol |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Psoriatic Arthropathy |
1.4% |
| Cardiac Disorder |
1.4% |
|
| Wrong Technique In Drug Usage Process |
22.8% |
| Drug Ineffective |
8.1% |
| Flushing |
7.8% |
| Product Quality Issue |
6.0% |
| Pruritus |
5.3% |
| Vomiting |
5.3% |
| Pain |
4.6% |
| Injection Site Pain |
4.0% |
| Weight Increased |
3.9% |
| Nausea |
3.8% |
| Weight Decreased |
3.8% |
| Rash |
3.6% |
| Dyspnoea |
2.9% |
| Somnolence |
2.8% |
| Tremor |
2.8% |
| Fatigue |
2.8% |
| Psoriasis |
2.5% |
| Pharmaceutical Product Complaint |
2.5% |
| Pyrexia |
2.4% |
| Paraesthesia |
2.4% |
|
| Interacting |
| Product Used For Unknown Indication |
76.4% |
| Pain |
3.2% |
| Hiv Infection |
2.5% |
| Dementia |
1.9% |
| Anxiety |
1.3% |
| Back Pain |
1.3% |
| Crohn's Disease |
1.3% |
| Depression |
1.3% |
| Drug Use For Unknown Indication |
1.3% |
| Muscle Spasms |
1.3% |
| Premedication |
1.3% |
| Schizoaffective Disorder |
1.3% |
| Upper Respiratory Tract Infection |
1.3% |
| Arthralgia |
0.6% |
| Blood Testosterone Decreased |
0.6% |
| Chronic Obstructive Pulmonary Disease |
0.6% |
| Dementia Alzheimer's Type |
0.6% |
| Gastric Disorder |
0.6% |
| Gastritis |
0.6% |
| Hyperthyroidism |
0.6% |
|
| Drug Interaction |
30.8% |
| Respiratory Depression |
7.7% |
| Sternal Fracture |
7.7% |
| Toxicity To Various Agents |
7.7% |
| Anaphylactic Shock |
3.8% |
| Arrhythmia |
3.8% |
| Dementia |
3.8% |
| Local Swelling |
3.8% |
| Overdose |
3.8% |
| Psychotic Disorder |
3.8% |
| Rash |
3.8% |
| Restlessness |
3.8% |
| Thermal Burn |
3.8% |
| Urticaria |
3.8% |
| Viral Load Increased |
3.8% |
| Virologic Failure |
3.8% |
|
